Charani Ranasinghe

Affiliated with

Research Area

Biography

Charani Ranasinghe has not added Biography.
If you are Charani Ranasinghe and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 12	2014

Other Publications

Article	Year
Matrix assisted laser desorption ionisation time of flight mass spectrometry (MALDI-TOF MS) for detecting novel Bt toxins. Journal of invertebrate pathology\| PubMed ID: 12054787	2002
Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use. Vaccine\| PubMed ID: 15964105	2005
Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with C... Vaccine\| PubMed ID: 15985317	2005
Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1. Vaccine\| PubMed ID: 16759767	2006
Prime-boost strategies in DNA vaccines. Methods in molecular medicine\| PubMed ID: 16988455	2006
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine. Vaccine\| PubMed ID: 17050052	2006
Mucosal HIV-1 pox virus prime-boost immunization induces high-avidity CD8+ T cells with regime-dependent cytokine/granzyme B profiles. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 17277143	2007
Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18490714	2008
Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity. European journal of immunology\| PubMed ID: 19582753	2009
Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity. Expert review of vaccines\| PubMed ID: 19722891	2009
Human immunodeficiency virus-1 vaccine design: where do we go now? Immunology and cell biology\| PubMed ID: 20956986	2011
Evaluating vaccinia virus cytokine co-expression in TLR GKO mice. Immunology and cell biology\| PubMed ID: 21173782	2011
A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations. Vaccine\| PubMed ID: 21352941	2011
Role of novel type I interferon epsilon in viral infection and mucosal immunity. Mucosal immunology\| PubMed ID: 22617838	2012
Fluorescent target array killing assay: a multiplex cytotoxic T-cell assay to measure detailed T-cell antigen specificity and avidity in vivo. Cytometry. Part A : the journal of the International Society for Analytical Cytology\| PubMed ID: 22740235	2012
Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo. Journal of immunological methods\| PubMed ID: 23123200	2013
Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity. PloS one\| PubMed ID: 23383283	2013
CCR6 is transiently upregulated on B cells after activation and modulates the germinal center reaction in the mouse. Immunology and cell biology\| PubMed ID: 23588497	2013
IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination. Vaccine\| PubMed ID: 23933364	2013
New advances in mucosal vaccination. Immunology letters\| PubMed ID: 24462961	2014
Progresses in DNA-based heterologous prime-boost immunization strategies. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 24715282	2014